Vincristine, adriamycin, and mitomycin (VAM) therapy for previously treated breast cancer. A preliminary report.


Fifteen patients with metastatic breast cancer previously treated with chemotherapy were treated with a regimen consisting of vincristine, Adriamycin, and mitomycin. Eleven patients (73%) responded with three complete and eight partial responses. The median duration of response was eight months. While all four nonresponders died within five months, the… (More)


  • Presentations referencing similar topics